{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:24:48Z","timestamp":1791897888454,"version":"4.3.4"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.addr.2021.04.021","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T03:10:17Z","timestamp":1619147417000},"page":"190-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Next generation strategies for preventing preterm birth"],"prefix":"10.1016","volume":"174","author":[{"given":"Hannah C.","family":"Zierden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3244-8278","authenticated-orcid":false,"given":"Rachel L.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"DeLong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davell M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.04.021_b0005","series-title":"Williams Obstetrics","author":"Gary Cunningham","year":"2018"},{"key":"10.1016\/j.addr.2021.04.021_b0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.08.010","article-title":"Microphysiological systems of the placental barrier","volume":"161\u2013162","author":"Arumugasaamy","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.04.021_b0015","unstructured":"CDC Infant Mortality, 2019. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/infantmortality.htm (accessed 09\/17 2019)."},{"key":"10.1016\/j.addr.2021.04.021_b0020","unstructured":"M.O. Dimes, 2020 March of Dimes Report CARD, marchofdimes.org\/reportcard, 2020."},{"key":"10.1016\/j.addr.2021.04.021_b0025","unstructured":"CDC, Preterm Birth, 2019. https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/pretermbirth.htm (accessed 09\/17\/2019)."},{"issue":"24","key":"10.1016\/j.addr.2021.04.021_b0030","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1001\/jama.296.24.2907","article-title":"Groups take aim at US preterm birth rate","volume":"296","author":"Kuehn","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0165025417692899","article-title":"Trajectories of problem behaviors from 4 to 23 years in former preterm infants","volume":"42","author":"Scott","year":"2018","journal-title":"Int. J. Behav. Dev."},{"key":"10.1016\/j.addr.2021.04.021_b0040","doi-asserted-by":"crossref","unstructured":"M.E. Msall et al., Life Course Health Development Outcomes After Prematurity: Developing a Community, Clinical, and Translational Research Agenda to Optimize Health, Behavior, and Functioning, in: N. Halfon et al. (Eds.), Handbook of Life Course Health Development, 2018, pp. 321\u2013348.","DOI":"10.1007\/978-3-319-47143-3_14"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1744-6155.2012.00337.x","article-title":"17-year outcome of preterm infants with diverse neonatal morbidities: Part 1\u2013Impact on physical, neurological, and psychological health status","volume":"17","author":"Sullivan","year":"2012","journal-title":"J. Spec. Pediatr. Nurs."},{"issue":"Suppl 1","key":"10.1016\/j.addr.2021.04.021_b0050","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod. Health"},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0055","first-page":"60","article-title":"Progesterone supplementation and the prevention of preterm birth","volume":"4","author":"Norwitz","year":"2011","journal-title":"Rev. Obstet. Gynecol."},{"issue":"Suppl 3","key":"10.1016\/j.addr.2021.04.021_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"Bjog"},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0065","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0002-9378(98)70544-7","article-title":"The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","volume":"178","author":"Iams","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9606","key":"10.1016\/j.addr.2021.04.021_b0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.siny.2016.01.005","article-title":"Risk assessment and management to prevent preterm birth","volume":"21","author":"Koullali","year":"2016","journal-title":"Semin. Fetal Neonatal Med."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0080","doi-asserted-by":"crossref","first-page":"276 e1","DOI":"10.1016\/j.ajog.2015.09.006","article-title":"Efficacy of midtrimester short cervix interventions is conditional on intraamniotic inflammation","volume":"214","author":"Kiefer","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/a-0611-5337","article-title":"Controversies about the Secondary Prevention of Spontaneous Preterm Birth","volume":"78","author":"Kyvernitakis","year":"2018","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1515\/jpm-2017-0014","article-title":"Risk of preterm birth by maternal age at first and second pregnancy and race\/ethnicity","volume":"46","author":"Baer","year":"2018","journal-title":"J. Perinat. Med."},{"issue":"12","key":"10.1016\/j.addr.2021.04.021_b0095","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.283.12.1591","article-title":"Rates of and factors associated with recurrence of preterm delivery","volume":"283","author":"Adams","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajog.2006.05.022","article-title":"Recurrence of spontaneous versus medically indicated preterm birth","volume":"195","author":"Ananth","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/AOG.0000000000001506","article-title":"Recurrence of Preterm Birth and Early Term Birth","volume":"128","author":"Yang","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.siny.2017.11.007","article-title":"Screening for spontaneous preterm birth and resultant therapies to reduce neonatal morbidity and mortality: A review","volume":"23","author":"Glover","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0115","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7863\/jum.2011.30.7.997","article-title":"Cervical length changes from the first to second trimester of pregnancy, and prediction of preterm birth by first-trimester sonographic cervical measurement","volume":"30","author":"Souka","year":"2011","journal-title":"J. Ultrasound Med."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0120","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1469-0705.1998.12050312.x","article-title":"Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery","volume":"12","author":"Heath","year":"1998","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/JPM.2006.002","article-title":"A sonographic short cervix as the only clinical manifestation of intra-amniotic infection","volume":"34","author":"Hassan","year":"2006","journal-title":"J. Perinat. Med."},{"issue":"Pt 20","key":"10.1016\/j.addr.2021.04.021_b0130","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Pankov","year":"2002","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.addr.2021.04.021_b0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.semperi.2017.08.002","article-title":"Predicting preterm birth: Cervical length and fetal fibronectin","volume":"41","author":"Son","year":"2017","journal-title":"Semin. Perinatol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/whe.15.74","article-title":"Quantitative fetal fibronectin to predict spontaneous preterm birth: a review","volume":"12","author":"Hezelgrave","year":"2016","journal-title":"Womens Health (Lond)"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0145","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1074\/jbc.M112.424366","article-title":"Fetal fibronectin signaling induces matrix metalloproteases and cyclooxygenase-2 (COX-2) in amnion cells and preterm birth in mice","volume":"288","author":"Mogami","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7359","key":"10.1016\/j.addr.2021.04.021_b0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmj.325.7359.301","article-title":"Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review","volume":"325","author":"Honest","year":"2002","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.addr.2021.04.021_b0155","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.2017.1373","article-title":"Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women","volume":"317","author":"Esplin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2021.04.021_b0160","unstructured":"J. Gao, Preterm Birth Prediction by Measurement of Biomarkers in Cervical Vaginal Fluid (PBMBCVF). ClinicalTrials.gov Identifier: NCT03974724, 2019."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0165","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.19119","article-title":"Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis","volume":"52","author":"Melchor","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.addr.2021.04.021_b0170","unstructured":"P.-L. Diagnostics, Amniotest, in: P.-L. Incorporated (Ed.), 2015."},{"key":"10.1016\/j.addr.2021.04.021_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2021.01.007","article-title":"Data-Driven Modeling of Pregnancy-Related Complications","author":"Espinosa","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/uog.20422","article-title":"Development and validation of predictive models for QUiPP App vol 2: tool for predicting preterm birth in women with symptoms of threatened preterm labor","volume":"55","author":"Carter","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0185","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/uog.20401","article-title":"Development and validation of predictive models for QUiPP App vol 2: tool for predicting preterm birth in asymptomatic high-risk women","volume":"55","author":"Watson","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.addr.2021.04.021_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.midw.2020.102864","article-title":"Impact of a medical mobile phone app (QUiPP) for predicting preterm birth on the anxiety and decisional conflicts faced by women in threatened preterm labour","volume":"92","author":"Carlisle","year":"2021","journal-title":"Midwifery"},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"21","key":"10.1016\/j.addr.2021.04.021_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218266","article-title":"The Cervicovaginal Mucus Barrier","volume":"21","author":"Lacroix","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0205","first-page":"371","article-title":"Vaginal microbiome","volume":"83","author":"Buchta","year":"2018","journal-title":"Ceska Gynekol."},{"issue":"11","key":"10.1016\/j.addr.2021.04.021_b0210","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","article-title":"The prevalence of bacterial vaginosis in the United States, 2001\u20132004; associations with symptoms, sexual behaviors, and reproductive health","volume":"34","author":"Koumans","year":"2007","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.addr.2021.04.021_b0215","article-title":"Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis","author":"Olson","year":"2017","journal-title":"Sex Health"},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.olq.0000200551.07573.df","article-title":"Bacterial Vaginosis: Risk factors among Kenyan women and their male partners","volume":"33","author":"Bukusi","year":"2006","journal-title":"Sex. Transm. Dis."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001251","article-title":"Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples","volume":"9","author":"Cohen","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.addr.2021.04.021_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100797","article-title":"Prenatal and postnatal contributions of the maternal microbiome on offspring programming","volume":"55","author":"Jasarevic","year":"2019","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.addr.2021.04.021_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.11.582","article-title":"Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix","author":"Gerson","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"37","key":"10.1016\/j.addr.2021.04.021_b0240","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.1073\/pnas.1705899114","article-title":"Replication and refinement of a vaginal microbial signature of preterm birth in two racially distinct cohorts of US women","volume":"114","author":"Callahan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"35","key":"10.1016\/j.addr.2021.04.021_b0245","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1073\/pnas.1502875112","article-title":"Temporal and spatial variation of the human microbiota during pregnancy","volume":"112","author":"DiGiulio","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 1","key":"10.1016\/j.addr.2021.04.021_b0250","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0255","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41591-019-0450-2","article-title":"The vaginal microbiome and preterm birth","volume":"25","author":"Fettweis","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.04.021_b0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.12.046","article-title":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","volume":"295","author":"Hoang","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0265","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-019-09285-9","article-title":"Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery","volume":"10","author":"Elovitz","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.04.021_b0270","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3389\/fmicb.2018.02181","article-title":"Common Cervicovaginal Microbial Supernatants Alter Cervical Epithelial Function: Mechanisms by Which Lactobacillus crispatus Contributes to Cervical Health","volume":"9","author":"Anton","year":"2018","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0275","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0002-9378(11)90785-6","article-title":"Does \u201cidiopathic\u201d preterm labor resulting in preterm birth exist?","volume":"168","author":"Lettieri","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0280","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/1933719117698583","article-title":"Properties of Epithelial Cells and Vaginal Secretions in Pregnant Women When Lactobacillus crispatus or Lactobacillus iners Dominate the Vaginal Microbiome","volume":"25","author":"Leizer","year":"2018","journal-title":"Reprod Sci"},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0285","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00460-13","article-title":"Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections","volume":"4","author":"Witkin","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.addr.2021.04.021_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.102127","article-title":"Microbial supernatants from Mobiluncus mulieris, a bacteria strongly associated with spontaneous preterm birth, disrupts the cervical epithelial barrier through inflammatory and miRNA mediated mechanisms","volume":"61","author":"Dude","year":"2020","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008236","article-title":"The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis","volume":"16","author":"Hoang","year":"2020","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0300","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2007.01.001","article-title":"Role of antibiotic therapy for bacterial vaginosis and intermediate flora in pregnancy","volume":"21","author":"Ugwumadu","year":"2007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1701-2163(16)32350-7","article-title":"The effect of second-trimester antibiotic therapy on the rate of preterm birth","volume":"29","author":"Morency","year":"2007","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.addr.2021.04.021_b0310","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/157159","article-title":"Antimicrobials for preterm birth prevention: an overview","volume":"2012","author":"Subramaniam","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.addr.2021.04.021_b0315","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/503780","article-title":"High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2021.04.021_b0320","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fcimb.2020.00354","article-title":"Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities","volume":"10","author":"Redelinghuys","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0325","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41598-018-36964-2","article-title":"Association between preterm delivery and bacterial vaginosis with or without treatment","volume":"9","author":"Shimaoka","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0330","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1542-2011.2011.00086.x","article-title":"Bacterial vaginosis and preterm birth","volume":"56","author":"Manns-James","year":"2011","journal-title":"J Midwifery Womens Health"},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0335","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/AOG.0b013e31821c6fb1","article-title":"Deus ex Makena?","volume":"117","author":"Silver","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2021.04.021_b0340","unstructured":"A.P. Inc., Makena, 2018. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2011\/021945_makena_toc.cfm (accessed)."},{"issue":"24","key":"10.1016\/j.addr.2021.04.021_b0345","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2021.04.021_b0350","first-page":"241","article-title":"Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth","volume":"11","author":"Travanty","year":"2018","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.addr.2021.04.021_b0355","article-title":"17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial","author":"Blackwell","year":"2019","journal-title":"Am. J Perinatol."},{"issue":"12","key":"10.1016\/j.addr.2021.04.021_b0360","first-page":"36","article-title":"Progesterone supplementation does not PROLONG pregnancy in women at risk for preterm birth: What do we do now?","volume":"31","author":"Michael House","year":"2019","journal-title":"MDedge ObGyn"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0365","first-page":"15","article-title":"Results from the PROLONG trial may shake up treatment options for recurrent preterm birth","volume":"32","author":"Pauli","year":"2020","journal-title":"MDedge ObGyn"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0370","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ajogmf.2019.03.001","article-title":"Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis","volume":"1","author":"Boelig","year":"2019","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0375","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijgo.2008.08.029","article-title":"Oral micronized progesterone for prevention of preterm birth","volume":"104","author":"Rai","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"12","key":"10.1016\/j.addr.2021.04.021_b0380","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/aogs.13236","article-title":"The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial","volume":"96","author":"Ashoush","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0385","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13063-020-4067-z","article-title":"Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"21","author":"Cheung","year":"2020","journal-title":"Trials"},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0390","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.fertnstert.2010.02.033","article-title":"Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study","volume":"94","author":"Yanushpolsky","year":"2010","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0395","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0400","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"10033","key":"10.1016\/j.addr.2021.04.021_b0405","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0410","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth \u2264 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0415","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","article-title":"Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data","volume":"218","author":"Romero","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0420","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/14767058.2012.755165","article-title":"Matched sample comparison of intramuscular versus vaginal micronized progesterone for prevention of preterm birth","volume":"26","author":"El-Gharib","year":"2013","journal-title":"J. Matern. Fetal Neonatal. Med."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0425","doi-asserted-by":"crossref","first-page":"399 e1","DOI":"10.1016\/j.ajog.2018.06.011","article-title":"Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women","volume":"219","author":"Andrikopoulou","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/ebnurs-2018-102998","article-title":"Low-dose aspirin as a promising agent for the prevention of spontaneous preterm birth","volume":"22","author":"Landman","year":"2019","journal-title":"Evid Based Nurs"},{"issue":"10220","key":"10.1016\/j.addr.2021.04.021_b0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"10220","key":"10.1016\/j.addr.2021.04.021_b0440","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0140-6736(20)30106-9","article-title":"Simple and safe: preventing preterm birth with aspirin","volume":"395","author":"Quinlivan","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0445","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12884-017-1244-5","article-title":"Assessment of DHA on reducing early preterm birth: the ADORE randomized controlled trial protocol","volume":"17","author":"Carlson","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.addr.2021.04.021_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102207","article-title":"The influence of DHA supplementation during pregnancy on language development across childhood: Follow-up of a randomised controlled trial","volume":"163","author":"Gawlik","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0455","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrendo.2016.37","article-title":"Micronutrient deficiencies in pregnancy worldwide: health effects and prevention","volume":"12","author":"Gernand","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.addr.2021.04.021_b0460","first-page":"CD008991","article-title":"Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy","volume":"6","author":"Alfirevic","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.addr.2021.04.021_b0465","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/aogs.13968","article-title":"Emergency cerclage in singleton pregnancies with painless cervical dilatation: A meta-analysis","volume":"99","author":"Chatzakis","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061270","article-title":"Emergency Cervical Cerclage","volume":"10","author":"Wierzchowska-Opoka","year":"2021","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.addr.2021.04.021_b0475","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.semperi.2017.08.009","article-title":"Prevention of preterm birth: Novel interventions for the cervix","volume":"41","author":"Koullali","year":"2017","journal-title":"Semin. Perinatol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.046","article-title":"Injectable silk-based biomaterials for cervical tissue augmentation: an in vitro study","volume":"214","author":"Brown","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.addr.2021.04.021_b0485","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1177\/1933719114522551","article-title":"Biocompatibility of a sonicated silk gel for cervical injection during pregnancy: in vivo and in vitro study","volume":"21","author":"Critchfield","year":"2014","journal-title":"Reprod Sci"},{"issue":"7094","key":"10.1016\/j.addr.2021.04.021_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(59)92242-1","article-title":"Treatment of habitual abortion due to cervical incompetence","volume":"274","author":"Cross","year":"1959","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0495","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-2008-1026276","article-title":"The Arabin cerclage pessary\u2013an alternative to surgical cerclage","volume":"50","author":"Quaas","year":"1990","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"23","key":"10.1016\/j.addr.2021.04.021_b0500","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1001\/jama.2017.18956","article-title":"Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial","volume":"318","author":"Saccone","year":"2017","journal-title":"JAMA"},{"issue":"9828","key":"10.1016\/j.addr.2021.04.021_b0505","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(12)60030-0","article-title":"Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial","volume":"379","author":"Goya","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2021.04.021_b0510","unstructured":"T.R.-B. C\u00e9line Chauleur, Edouard Noblot, Claude-R\u00e9gis Lacoste, Amandine Stadler, C\u00e9cile Fanget, Thomas Corsini, Anne Genod, Suzanne Lima, Charlotte Vermersch, Laura Chauveau, Bertrand Ripamonti, Marie-Isabelle Cano, Laure-Elie Digonnet, Marianne Perrot, Tiphaine Semay, Camille Sarkis, Judica\u00eblle Montlouis-Calixte, Prevention of Preterm Birth in Singletons Using Pessary After Resolutive Threatened Preterm Labor (PREMAPESSAIRE). ClinicalTrials.gov Identifier: NCT02484820, 2020."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0515","first-page":"922","article-title":"Mouse models of preterm birth: suggested assessment and reporting guidelines","volume":"99","author":"McCarthy","year":"2018","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0520","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/gm438","article-title":"The genomics of preterm birth: from animal models to human studies","volume":"5","author":"Bezold","year":"2013","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0525","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jc.2017-02195","article-title":"Retosiban Prevents Stretch-Induced Human Myometrial Contractility and Delays Labor in Cynomolgus Monkeys","volume":"103","author":"Aye","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222817","article-title":"Oral dosing for antenatal corticosteroids in the Rhesus macaque","volume":"14","author":"Schmidt","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.028","article-title":"Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates","volume":"213","author":"Adams Waldorf","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0540","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/pr.2017.57","article-title":"Beyond the uterine environment: a nonhuman primate model to investigate maternal-fetal and neonatal outcomes following chronic intrauterine infection","volume":"82","author":"Kelleher","year":"2017","journal-title":"Pediatr. Res."},{"issue":"7\u20138","key":"10.1016\/j.addr.2021.04.021_b0545","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1242\/dmm.001701","article-title":"Preventing preterm birth: the past limitations and new potential of animal models","volume":"3","author":"Ratajczak","year":"2010","journal-title":"Dis Model Mech"},{"issue":"8","key":"10.1016\/j.addr.2021.04.021_b0550","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/0002-9378(67)90031-2","article-title":"Failure of initiation of parturition after electrocoagulation of the pituitary of the fetal lamb","volume":"98","author":"Liggins","year":"1967","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0555","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s10020-020-00206-x","article-title":"Chorioamnionitis induces enteric nervous system injury: effects of timing and inflammation in the ovine fetus","volume":"26","author":"Heymans","year":"2020","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0560","doi-asserted-by":"crossref","first-page":"349 e1","DOI":"10.1016\/j.ajog.2017.12.207","article-title":"Extremely preterm fetal sheep lung responses to antenatal steroids and inflammation","volume":"218","author":"Visconti","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0565","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12974-020-01769-6","article-title":"Tumor necrosis factor inhibition attenuates white matter gliosis after systemic inflammation in preterm fetal sheep","volume":"17","author":"Galinsky","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"6 Pt 1","key":"10.1016\/j.addr.2021.04.021_b0570","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/0002-9378(90)90777-5","article-title":"A rabbit model for bacteria-induced preterm pregnancy loss","volume":"163","author":"Dombroski","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0575","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/00016349709047780","article-title":"Ability of intrauterine bacterial lipopolysaccharide to cause in situ uterine contractions in pregnant rabbits","volume":"76","author":"Katsuki","year":"1997","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0580","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2967\/jnumed.106.038539","article-title":"Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET","volume":"48","author":"Kannan","year":"2007","journal-title":"J. Nucl. Med."},{"issue":"130","key":"10.1016\/j.addr.2021.04.021_b0585","doi-asserted-by":"crossref","first-page":"130ra46","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0590","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3181\/00379727-54-14424","article-title":"Induction of Decidua-Placental Hemorrhage in Mice by the Endotoxins of Certain Gram-Negative Bacteria","volume":"54","author":"Zahl","year":"1943","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0595","first-page":"380","article-title":"5 alpha-reduced androgens play a key role in murine parturition","volume":"10","author":"Mahendroo","year":"1996","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0600","first-page":"981","article-title":"The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening","volume":"13","author":"Mahendroo","year":"1999","journal-title":"Mol. Endocrinol."},{"issue":"19","key":"10.1016\/j.addr.2021.04.021_b0605","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1073\/pnas.1200650109","article-title":"MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor","volume":"109","author":"Williams","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0610","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0002-9378(87)80315-0","article-title":"Effects of the antiprogesterone RU 486 on preterm birth in the rat","volume":"157","author":"Garfield","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0615","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/en.2010-1105","article-title":"The molecular mechanisms of cervical ripening differ between term and preterm birth","volume":"152","author":"Holt","year":"2011","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.03.025","article-title":"Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle","volume":"202","author":"Kuon","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0625","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/0002-9378(95)90503-0","article-title":"A model of intrauterine infection and preterm delivery in mice","volume":"172","author":"Hirsch","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0630","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1067\/mob.2002.120278","article-title":"Bacterially induced preterm labor in the mouse does not require maternal interleukin-1 signaling","volume":"186","author":"Hirsch","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0635","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0897.2012.01110.x","article-title":"Models of fetal brain injury, intrauterine inflammation, and preterm birth","volume":"67","author":"Burd","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0640","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0002-9440(10)63567-5","article-title":"A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4","volume":"163","author":"Elovitz","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.01.022","article-title":"Magnesium sulfate reduces inflammation-associated brain injury in fetal mice","volume":"202","author":"Burd","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b0650","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/jnr.22368","article-title":"Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain","volume":"88","author":"Burd","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0655","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajog.2006.06.013","article-title":"The use of progestational agents for preterm birth: lessons from a mouse model","volume":"195","author":"Elovitz","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0660","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.siny.2006.03.005","article-title":"Anti-inflammatory interventions in pregnancy: now and the future","volume":"11","author":"Elovitz","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0665","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1095\/biolreprod.108.075309","article-title":"Preterm and term cervical ripening in CD1 Mice (Mus musculus): similar or divergent molecular mechanisms?","volume":"81","author":"Gonzalez","year":"2009","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0670","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2353\/ajpath.2006.050207","article-title":"Disruption of interleukin-18, but not interleukin-1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammation","volume":"169","author":"Wang","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0675","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/14767050801923680","article-title":"Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth","volume":"21","author":"Elovitz","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0680","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1933719108325757","article-title":"Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birth","volume":"16","author":"Yellon","year":"2009","journal-title":"Reprod Sci"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0685","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1582-4934.2012.01650.x","article-title":"Myometrial immune cells contribute to term parturition, preterm labour and post-partum involution in mice","volume":"17","author":"Shynlova","year":"2013","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0690","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajog.2003.10.693","article-title":"Medroxyprogesterone acetate, but not progesterone, protects against inflammation-induced parturition and intrauterine fetal demise","volume":"190","author":"Elovitz","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b0695","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.ajpath.2015.05.015","article-title":"Specific Lipopolysaccharide Serotypes Induce Differential Maternal and Neonatal Inflammatory Responses in a Murine Model of Preterm Labor","volume":"185","author":"Migale","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2021.04.021_b0700","article-title":"Characterization of an Adapted Murine Model of Intrauterine Inflammation-Induced Preterm Birth","author":"Zierden","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191524","article-title":"Colonization of the cervicovaginal space with Gardnerella vaginalis leads to local inflammation and cervical remodeling in pregnant mice","volume":"13","author":"Sierra","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059539","article-title":"Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis","volume":"8","author":"Gilbert","year":"2013","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.addr.2021.04.021_b0715","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.ajpath.2018.06.016","article-title":"Ascending Vaginal Infection Using Bioluminescent Bacteria Evokes Intrauterine Inflammation, Preterm Birth, and Neonatal Brain Injury in Pregnant Mice","volume":"188","author":"Suff","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"40","key":"10.1016\/j.addr.2021.04.021_b0720","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.2174\/1381612823666171012101114","article-title":"Discrepancies in Animal Models of Preterm Birth","volume":"23","author":"Manuel","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0725","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.clp.2018.01.015","article-title":"Perinatal Brain Injury: Mechanisms, Prevention, and Outcomes","volume":"45","author":"Novak","year":"2018","journal-title":"Clin. Perinatol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.013","article-title":"Beyond white matter damage: fetal neuronal injury in a mouse model of preterm birth","volume":"201","author":"Burd","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0735","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ijdevneu.2011.02.011","article-title":"Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury","volume":"29","author":"Elovitz","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.addr.2021.04.021_b0740","article-title":"Developmental Milestones in the Newborn Mouse. Neuromethods 39: Neuropeptide","volume":"17","author":"Hill","year":"2008","journal-title":"Techniques"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0745","doi-asserted-by":"crossref","first-page":"283 e1","DOI":"10.1016\/j.ajog.2016.08.027","article-title":"Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor","volume":"216","author":"Paul","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"576","key":"10.1016\/j.addr.2021.04.021_b0750","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc6245","article-title":"Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth","volume":"13","author":"Zierden","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0755","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133761","article-title":"Computational discovery of therapeutic candidates for preventing preterm birth","volume":"5","author":"Le","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.addr.2021.04.021_b0760","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.placenta.2019.01.018","article-title":"Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches","volume":"79","author":"Mesiano","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.addr.2021.04.021_b0765","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bpobgyn.2018.03.008","article-title":"Rationale for current and future progestin-based therapies to prevent preterm birth","volume":"52","author":"Weatherborn","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0770","doi-asserted-by":"crossref","first-page":"E719","DOI":"10.1210\/jc.2011-3251","article-title":"Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition","volume":"97","author":"Tan","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2021.04.021_b0775","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1038\/ncomms11565","article-title":"Molecular evidence of functional progesterone withdrawal in human myometrium","volume":"7","author":"Nadeem","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0780","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1038\/s41598-017-13488-9","article-title":"Progesterone Via its Type-A Receptor Promotes Myometrial Gap Junction Coupling","volume":"7","author":"Nadeem","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0785","first-page":"158","article-title":"Inflammatory Stimuli Increase Progesterone Receptor-A Stability and Transrepressive Activity in Myometrial Cells","volume":"158","author":"Peters","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.addr.2021.04.021_b0790","doi-asserted-by":"crossref","first-page":"4589214","DOI":"10.1155\/2017\/4589214","article-title":"Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium","volume":"2017","author":"Ilicic","year":"2017","journal-title":"Biomed Res. Int."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0795","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/13697137.2017.1386650","article-title":"Selective progesterone receptor modulators: current applications and perspectives","volume":"21","author":"Chabbert-Buffet","year":"2018","journal-title":"Climacteric"},{"issue":"11","key":"10.1016\/j.addr.2021.04.021_b0800","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1210\/en.2016-1654","article-title":"Human Parturition Involves Phosphorylation of Progesterone Receptor-A at Serine-345 in Myometrial Cells","volume":"157","author":"Amini","year":"2016","journal-title":"Endocrinology"},{"issue":"16","key":"10.1016\/j.addr.2021.04.021_b0805","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.1633616100","article-title":"A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition","volume":"100","author":"Condon","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.addr.2021.04.021_b0810","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsbmb.2013.02.008","article-title":"Progesterone, inflammation and preterm labor","volume":"139","author":"Parizek","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0815","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/REP-11-0466","article-title":"Cervical remodeling in term and preterm birth: insights from an animal model","volume":"143","author":"Mahendroo","year":"2012","journal-title":"Reproduction"},{"issue":"8","key":"10.1016\/j.addr.2021.04.021_b0820","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogrm.2010.05.001","article-title":"Drugs acting on the pregnant uterus","volume":"20","author":"Arrowsmith","year":"2010","journal-title":"Obstet. Gynaecol. Reprod. Med."},{"key":"10.1016\/j.addr.2021.04.021_b0825","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/IJWH.S44048","article-title":"Short-term tocolytics for preterm delivery - current perspectives","volume":"6","author":"Haas","year":"2014","journal-title":"Int. J. Womens Health"},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0830","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1096\/fj.201801104R","article-title":"Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models","volume":"33","author":"Boyle","year":"2019","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0835","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clp.2019.02.001","article-title":"Drugs for the Treatment and Prevention of Preterm Labor","volume":"46","author":"Patel","year":"2019","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.addr.2021.04.021_b0840","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/IJWH.S159062","article-title":"Effectiveness of nifedipine in threatened preterm labor: a randomized trial","volume":"10","author":"Songthamwat","year":"2018","journal-title":"Int. J. Womens Health"},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0845","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1381612825666190329124214","article-title":"Safety and Efficacy of Tocolytics for the Treatment of Spontaneous Preterm Labour","volume":"25","author":"Lamont","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0850","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.clp.2019.02.008","article-title":"Magnesium Sulfate and Novel Therapies to Promote Neuroprotection","volume":"46","author":"Jameson","year":"2019","journal-title":"Clin. Perinatol."},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0855","first-page":"444","article-title":"Magnesium sulfate for prevention of preterm birth","volume":"91","author":"Seehusen","year":"2015","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0860","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41390-019-0557-7","article-title":"Magnesium sulfate inhibits inflammation through P2X7 receptors in human umbilical vein endothelial cells","volume":"87","author":"Ozen","year":"2020","journal-title":"Pediatr. Res."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b0865","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1096\/fj.201601323RR","article-title":"Bitter taste receptors as targets for tocolytics in preterm labor therapy","volume":"31","author":"Zheng","year":"2017","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b0870","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2174\/1381612824666180130121706","article-title":"Repurposing N, N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and\/or Treatment of Preterm Birth","volume":"24","author":"Gorasiya","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0875","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajpath.2013.05.006","article-title":"N, N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth","volume":"183","author":"Sundaram","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b0880","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13151","article-title":"Administration of melatonin for prevention of preterm birth and fetal brain injury associated with premature birth in a mouse model","volume":"82","author":"Lee","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0885","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-079X.2005.00274.x","article-title":"Melatonin protects against lipopolysaccharide-induced intra-uterine fetal death and growth retardation in mice","volume":"40","author":"Chen","year":"2006","journal-title":"J. Pineal Res."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b0890","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2174\/1381612824666180130122450","article-title":"Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?","volume":"24","author":"Robertson","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2021.04.021_b0895","doi-asserted-by":"crossref","first-page":"36112","DOI":"10.1038\/srep36112","article-title":"Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth","volume":"6","author":"Chin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.04.021_b0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2020.01.008","article-title":"Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice","author":"Wahid","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0905","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.1502055","article-title":"An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment","volume":"196","author":"Xu","year":"2016","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.addr.2021.04.021_b0910","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1177\/1933719117697128","article-title":"Rosiglitazone Regulates TLR4 and Rescues HO-1 and NRF2 Expression in Myometrial and Decidual Macrophages in Inflammation-Induced Preterm Birth","volume":"24","author":"Kadam","year":"2017","journal-title":"Reprod. Sci."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b0915","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/bph.12069","article-title":"PPAR-gamma \u2013 a possible drug target for complicated pregnancies","volume":"168","author":"McCarthy","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0920","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/db06-0915","article-title":"A possible role for the PPARG Pro12Ala polymorphism in preterm birth","volume":"56","author":"Meirhaeghe","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0925","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000710","article-title":"The pregnant myometrium is epigenetically activated at contractility-driving gene loci prior to the onset of labor in mice","volume":"18","author":"Shchuka","year":"2020","journal-title":"PLoS Biol."},{"issue":"11","key":"10.1016\/j.addr.2021.04.021_b0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143243","article-title":"High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility","volume":"10","author":"Herington","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.04.021_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery","author":"Zierden","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0940","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1538-7836.2005.01328.x","article-title":"Spatial and temporal dynamics of the endothelium","volume":"3","author":"Aird","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b0945","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0950","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/beog.2001.0231","article-title":"Drugs in pregnancy. Pharmacokinetics in pregnancy","volume":"15","author":"Dawes","year":"2001","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0955","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41598-018-37002-x","article-title":"Exosomes Cause Preterm Birth in Mice: Evidence for Paracrine Signaling in Pregnancy","volume":"9","author":"Sheller-Miller","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.addr.2021.04.021_b0960","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd3865","article-title":"Exosomal delivery of NF-kappaB inhibitor delays LPS-induced preterm birth and modulates fetal immune cell profile in mouse models","volume":"7","author":"Sheller-Miller","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2021.04.021_b0965","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biomaterials.2016.05.044","article-title":"Nanoscale effects in dendrimer-mediated targeting of neuroinflammation","volume":"101","author":"Nance","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.04.021_b0970","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jconrel.2015.07.009","article-title":"Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury","volume":"214","author":"Nance","year":"2015","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0975","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10160","article-title":"Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration","volume":"5","author":"Liaw","year":"2020","journal-title":"Bioeng. Transl. Med."},{"issue":"2","key":"10.1016\/j.addr.2021.04.021_b0980","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1039\/D0NR05958G","article-title":"Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances beta-amyloid phagocytosis","volume":"13","author":"DeRidder","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2021.04.021_b0985","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2018.06.003","article-title":"Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model","volume":"283","author":"Sharma","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.addr.2021.04.021_b0990","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1038\/s41598-017-06113-2","article-title":"Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury","volume":"7","author":"Lei","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b0995","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.nano.2014.03.008","article-title":"Fetal uptake of intra-amniotically delivered dendrimers in a mouse model of intrauterine inflammation and preterm birth","volume":"10","author":"Burd","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2021.04.021_b1000","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jconrel.2014.04.033","article-title":"Nanoparticle-based drug delivery to the vagina: a review","volume":"190","author":"Ensign","year":"2014","journal-title":"J. Control. Release"},{"issue":"138","key":"10.1016\/j.addr.2021.04.021_b1005","doi-asserted-by":"crossref","first-page":"138ra79","DOI":"10.1126\/scitranslmed.3003453","article-title":"Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus","volume":"4","author":"Ensign","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"28","key":"10.1016\/j.addr.2021.04.021_b1010","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.biomaterials.2013.05.039","article-title":"Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake","volume":"34","author":"Ensign","year":"2013","journal-title":"Biomaterials"},{"issue":"21","key":"10.1016\/j.addr.2021.04.021_b1015","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/adhm.201600599","article-title":"Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces","volume":"5","author":"Yu","year":"2016","journal-title":"Adv. Healthc. Mater."},{"issue":"9","key":"10.1016\/j.addr.2021.04.021_b1020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.addr.2021.04.021_b1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048328","article-title":"Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity","volume":"7","author":"Dezzutti","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2021.04.021_b1030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/1471-2334-10-331","article-title":"Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse","volume":"10","author":"Moench","year":"2010","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.addr.2021.04.021_b1035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s13346-019-00646-x","article-title":"Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheep","volume":"9","author":"Weiss","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"7","key":"10.1016\/j.addr.2021.04.021_b1040","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070335","article-title":"17-alpha Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth","volume":"11","author":"Patki","year":"2019","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.addr.2021.04.021_b1045","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2217\/nnm-2019-0243","article-title":"A vaginal nanoformulation of a SphK inhibitor attenuates lipopolysaccharide-induced preterm birth in mice","volume":"14","author":"Giusto","year":"2019","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"10.1016\/j.addr.2021.04.021_b1050","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ajpath.2014.10.026","article-title":"Inhibition of sphingosine kinase prevents lipopolysaccharide-induced preterm birth and suppresses proinflammatory responses in a murine model","volume":"185","author":"Vyas","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.addr.2021.04.021_b1055","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/03639045.2020.1767125","article-title":"Electrospun metronidazole-loaded nanofibers for vaginal drug delivery","volume":"46","author":"Tugcu-Demiroz","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2021.04.021_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110756","article-title":"Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives","volume":"111","author":"Sofi","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1\u20132","key":"10.1016\/j.addr.2021.04.021_b1065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpharm.2018.01.043","article-title":"The development of progesterone-loaded nanofibers using pressurized gyration: A novel approach to vaginal delivery for the prevention of pre-term birth","volume":"540","author":"Brako","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:03:12Z","timestamp":1759208592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":213,"alternative-id":["S0169409X21001496"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.04.021","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next generation strategies for preventing preterm birth","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}